(Q47722127)

5 February 2018

title

Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6. (English)

1 reference

5 February 2018

1 reference

A Adedoyin

1

1 reference

5 February 2018

P A Arns

2

1 reference

5 February 2018

W O Richards

3

1 reference

5 February 2018

G R Wilkinson

4

1 reference

5 February 2018

R A Branch

5

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

5 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

5 February 2018

volume

64

1 reference

5 February 2018

page(s)

8-17

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

Antipyrine metabolism in acute hepatic porphyria in relapse and remission

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Metabolism of amylobarbitone in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Influence of acute viral hepatitis on phenytoin kinetics and protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Clinical pharmacokinetics in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Guide to drug dosage in hepatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Drug metabolism in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Substrate specificities and functions of the P450 cytochromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Human cytochromes P450: problems and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Antipyrine elimination and hepatic microsomal enzyme activity in patients with liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Determinants of serum antipyrine half-lives in patients with liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

The effect of liver disease on urine caffeine metabolite ratios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Theophylline disposition in patients with hepatic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

The disposition of dapsone in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Genetic polymorphism of S-mephenytoin hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Polymorphic hydroxylation of Debrisoquine in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Transection of the oesophagus for bleeding oesophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Comparison of gas chromatographic and high-performance liquid chromatographic assays for the determination of debrisoquine and its 4-hydroxy metabolite in human fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

The effects of age and liver disease on the disposition and elimination of diazepam in adult man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Dipyrone metabolism in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Triazolam in cirrhosis: pharmacokinetics and pharmacodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Drug metabolizing enzymes in the brain and cerebral microvessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990017-0

10.1016/S0009-9236(98)90017-0

7 January 2021

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9695714

1 reference

5 February 2018